BioSpace News Archive

Genetown

Ipsen to present new Bylvay® (odevixibat) data at annual ESPGHAN congress, showcasing commitment to furthering treatment for rare cholestatic liver diseases

Ipsen announced that new data from its growing rare disease portfolio will be presented at the 55th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition, taking place in Vienna, Austria 17-20 May 2023.

May 17, 2023
·
11 min read
New Clarivate Biopharma Dealmaking Report Reveals Investment Patterns Set to Impact the Future of Medicine

Clarivate Plc, a global leader in connecting people and organizations to intelligence they can trust to transform their world, released its new report, Biopharma Dealmaking in 2023.

May 17, 2023
·
6 min read
Philips launches AI-powered CT system to accelerate routine radiology and high-volume screening programs

Royal Philips, a global leader in health technology, announced the launch of the Philips CT 3500, a new high-throughput CT system targeting the needs of routine radiology and high-volume screening programs.

May 17, 2023
·
4 min read
Coave Therapeutics to Participate in Upcoming June 2023 Conferences

Coave Therapeutics, a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS and eye diseases, announces that it will participate at the following conferences.

May 17, 2023
·
2 min read
Philips announces exchange ratio for 2022 dividend

Royal Philips announced that the exchange ratio for the dividend for the year 2022 is 1 new common share for every 22.3906 existing common shares.

May 17, 2023
·
2 min read
Pharm Country

Henry Schein to Participate in Three Investor Conferences

Henry Schein, Inc. announced that the Company will present at the following investor conferences in May and June.

May 17, 2023
·
2 min read
Business

Kamada to Announce First Quarter 2023 Financial Results and Host Conference Call on May 24, 2023

Kamada Ltd. today announced that it will release financial results for the first quarter ended March 31, 2023, prior to the open of the U.S. financial markets on Wednesday, May 24, 2023.

May 17, 2023
·
2 min read
Drug Development

Tonix Pharmaceuticals Announces Pharmacology and Medicinal Chemistry Results that Reveal the Molecular Mechanism of Action of Tianeptine, the Active Ingredient of TNX-601 ER, in Treating Depression

Tonix Pharmaceuticals Holding Corp. today announced the molecular mechanism of action of tianeptine, the active ingredient of TNX-601 ER (tianeptine hemioxalate extended-release tablets), currently in Phase 2 clinical development for the treatment of major depressive disorder (MDD)*.

May 17, 2023
·
14 min read
Biotech Bay

Notable Labs to Present Predictive Precision Medicine Platform (PPMP) Data in Juvenile Myelomonocytic Leukemia (JMML) at European Hematology Association (EHA) Hybrid Congress June 8 – 15, 2023

Notable Labs, Inc. today announced an abstract has been accepted for poster presentation at the European Hematology Association (EHA) Hybrid Congress to be held in Frankfurt, Germany on June 8 – 15, 2023.

May 17, 2023
·
2 min read
Pharm Country

Elevar Therapeutics Submits New Drug Application to FDA for Combination of Rivoceranib and Camrelizumab as First-Line Treatment Option for Unresectable Hepatocellular Carcinoma

Elevar Therapeutics, Inc. today announced it submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational drug rivoceranib, an oral TKI, in combination with camrelizumab, a PD-1 inhibitor.

May 17, 2023
·
6 min read